Business Description
Panbela Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US69833W4042
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | -0.3 | |||||
Debt-to-Equity | -1.32 | |||||
Debt-to-EBITDA | -0.15 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 76.6 | |||||
3-Year EPS without NRI Growth Rate | 25 | |||||
3-Year FCF Growth Rate | 74.4 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
14-Day RSI | 3.51 | |||||
12-1 Month Momentum % | -44.41 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.17 | |||||
Quick Ratio | 0.17 | |||||
Cash Ratio | 0.02 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -962.7 | |||||
Shareholder Yield % | -653.7 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -197.57 | |||||
ROIC % | -276.54 | |||||
ROCE % | -806.5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.22 | |||||
EV-to-Forward-EBIT | -0.08 | |||||
EV-to-EBITDA | -0.22 | |||||
EV-to-Forward-EBITDA | -0.08 | |||||
EV-to-FCF | -0.25 | |||||
Earnings Yield (Greenblatt) % | -454.55 | |||||
FCF Yield % | -1139.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Panbela Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -211.633 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 3.51 | ||
14-Day ATR (€) | 0.000007 | ||
20-Day SMA (€) | 119.4 | ||
12-1 Month Momentum % | -44.41 | ||
52-Week Range (€) | 119.399997 - 205.199995 | ||
Shares Outstanding (Mil) | 4.85 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Panbela Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Panbela Therapeutics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Panbela Therapeutics Inc Frequently Asked Questions
What is Panbela Therapeutics Inc(STU:X70)'s stock price today?
When is next earnings date of Panbela Therapeutics Inc(STU:X70)?
Does Panbela Therapeutics Inc(STU:X70) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |